TXG | 10x Genomics, Inc. Class ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$65.29
+$3.66 (+5.94%)

10x Genomics, Inc. Class A (TXG) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $65.29 vs 50 $74.13 / 200 $41.00
Projection
No cross projected
Test
No active test
Last cross
Golden cross 15 Aug 2025 ยท projected 23 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $70.11 vs 50 $36.69 / 200 $31.59
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 16:00 ET

Price
between the two $65.29 vs 50 $76.81 / 200 $59.74
Projection
No cross projected
Test
No active test
Last cross
Golden cross 10 Nov 2025 ยท projected 13 bars out

Cross history

12
crosses on record since 2021
6 golden6 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
10 Nov 2025Golden4-hour13 bars outNot tested
20 Oct 2025Death4-hour23 bars out4 bar cross test
15 Aug 2025Golden moderatedaily23 bars outNot tested
26 Jun 2025Golden4-hour28 bars outโ€”
16 Oct 2024Death4-hour28 bars outโ€”

About TXG

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$236M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.